BlueDot

Estimating true size of the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of Congo as of May 22, 2026

This free report examines the likely true size of the current Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo (DRC). Official figures likely underestimate the scale of the outbreak, which genomic and epidemiological evidence suggests may have circulated undetected for nearly two months prior to recognition. To support outbreak size estimation,…

Your Risk Map Is Outdated: What the 2026 World Cup Reveals About the New Travel Health Landscape

<p>The World Cup is a massive event that will expose how profoundly the infectious disease landscape has changed in recent years. Organizations dealing with static assumptions about disease threats may be caught by surprise. On June 11, the 2026 World Cup kicks off across the United States, Canada, and Mexico. As the first tournament to&#8230;</p> <p>The post <a href="https://bluedot.global/your-risk-map-is-outdated-what-the-2026-world-cup-reveals-about-the-new-travel-health-landscape/">Your Risk Map Is Outdated: What the 2026 World Cup Reveals About the New Travel Health Landscape</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

What can we learn from Measles in the US?

<p>The largest US measles outbreak in over 25 years is unfolding, exposing a complex dynamic between risk, hesitancy and vaccination. Organizations everywhere can learn much from it. Nestled between the bigger cities of Charlotte and Greenville, Spartanburg County is home to 400,000 South Carolinians. Here, BMW operates its largest production facility, employing 11,000 people amidst&#8230;</p> <p>The post <a href="https://bluedot.global/what-can-we-learn-from-measles-in-the-us/">What can we learn from Measles in the US?</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

Beware the “Superflu” hype: How infectious disease surveillance goes beyond the headlines

<p>When it comes to outbreaks, media reporting is a critical resource—but its trade-offs cannot be ignored In 2025, country after country reported a significant rise in influenza infections, often a full month earlier than the typical start to the flu season. In the United States, Canada, Europe and Japan, cases grew rapidly, and severe infections&#8230;</p> <p>The post <a href="https://bluedot.global/beware-the-superflu-hype-how-infectious-disease-surveillance-goes-beyond-the-headlines/">Beware the &#8220;Superflu&#8221; hype: How infectious disease surveillance goes beyond the headlines</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

Tracking Infectious Threats: Key Outbreaks of 2025 and Risks for 2026

<p>The global infectious disease landscape is shifting faster than ever. In 2025, outbreaks and influenza-like illnesses (ILI) spread unpredictably, testing public health systems and organizational preparedness. As we head into 2026, knowing which signals truly matter—and understanding their potential impact on your community or operations—has never been more critical. In this webinar we explored how&#8230;</p> <p>The post <a href="https://bluedot.global/tracking-infectious-threats-key-outbreaks-of-2025-and-risks-for-2026/">Tracking Infectious Threats: Key Outbreaks of 2025 and Risks for 2026</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

The most notable infectious disease events of 2025

<p>Three battles we fought — and another we won — against emerging threats and resurgent foes over the past year From unexpected outbreaks that challenged global health systems to groundbreaking advancements in disease surveillance and prevention, this past year has been a whirlwind of activity in the world of infectious diseases and disease prevention. Widespread&#8230;</p> <p>The post <a href="https://bluedot.global/the-most-notable-infectious-disease-events-of-2025/">The most notable infectious disease events of 2025 </a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

How data blackouts and blind spots put organizations at risk

<p>The U.S. government shutdown demonstrates how infectious disease data sources can dry up — and how third-party surveillance sees in the dark The recent US government shutdown, lasting 43 days and furloughing around 670,000 federal employees, disrupted a multitude of programs and services. Not least among these were health research, disease surveillance, and expert public&#8230;</p> <p>The post <a href="https://bluedot.global/how-data-blackouts-and-blind-spots-put-organizations-at-risk/">How data blackouts and blind spots put organizations at risk</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

Local Matches, Global Risks: Infectious Disease Surveillance, Connectivity and the 2026 World Cup

<p>We have entered a new era of global mobility — one where mass gatherings and interconnected travel networks can rapidly amplify infectious disease risks. As the 2026 World Cup approaches, how can local public health teams prepare for the challenges that large-scale international events bring? In this webinar, we explored the intersection of disease surveillance,&#8230;</p> <p>The post <a href="https://bluedot.global/local-matches-global-risks-infectious-disease-surveillance-connectivity-and-the-2026-world-cup/">Local Matches, Global Risks: Infectious Disease Surveillance, Connectivity and the 2026 World Cup </a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

The measles stress test: What 2025 taught us about global readiness

<p>North America teeters on the edge of losing measles-free status, proving that disease elimination is not a finish line but a maintenance task Next Monday, October 27, Canada will lose its measles elimination status, a designation it has held for almost 30 years, due to a sustained series of measles outbreaks in the past year.&#8230;</p> <p>The post <a href="https://bluedot.global/the-measles-stress-test-what-2025-taught-us-about-global-readiness/">The measles stress test: What 2025 taught us about global readiness</a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

Navigating the coming wave of influenza-like illnesses

<p>The Northern Hemisphere’s flu season lurks around the corner. Better tracking, surveillance and analysis can help public health officials predict, plan and prevent. Every fall and winter, influenza-like illnesses (ILIs) — including seasonal flu, respiratory syncytial virus (RSV) and the less predictable COVID-19 — sweep the globe, driving widespread epidemics. Despite their anticipated occurrence, these&#8230;</p> <p>The post <a href="https://bluedot.global/navigating-the-coming-wave-of-influenza-like-illnesses/">Navigating the coming wave of influenza-like illnesses  </a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

Chikungunya goes global

<p>Once largely confined to Africa, the disease has taken hold in all parts of the world — with consequences for travelers and public health alike The spread of chikungunya, the mosquito-borne disease that causes debilitating joint pain, has resulted in more than 270,000 cases and 110 deaths to date in 2025 across southeast Asia, Europe&#8230;</p> <p>The post <a href="https://bluedot.global/chikungunya-goes-global/">Chikungunya goes global  </a> appeared first on <a href="https://bluedot.global">BlueDot</a>.</p>

How preparedness is evolving in the GCC region: Strengthening resilience to emerging infectious disease threats

BlueDot Awarded on Newsweek’s World’s Best Digital Health Companies

BlueDot Awarded on the Financial Times Americas’ Fastest Growing Companies 2024 List

BlueDot Strengthens Mpox Response with Advanced Surveillance Tools

BlueDot further innovates in respiratory surveillance for the 2024 ILI season

From signals to action: The future of global disease surveillance

BlueDot unveils next-gen global infectious disease surveillance solution, cutting manual detection time by nearly 90%